ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), a manufacturer and distributor of medical cannabis in Canada, announced on August 29 the achievement of working capital in the amount of $43 million from multiple financings, including strategic partnerships and private placements, during the six months ended June 30, 2017.
Algae Dynamics Corp. (OTCQB: ADYNF), a company engaged in developing unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils, is making international news through its current collaboration with the University of Western Ontario (now rebranded as Western University).
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), has seen a strong upward trend over the past few weeks, going from a close of $.27 at the end of August to $.50 currently on the back of strong announcements, and people are taking notice.
PotNetwork Holding, Inc. (OTC: POTN) this morning announced that its Diamond CBD subsidiary has been selected as an exclusive premier sponsor of Tommy Chong’s Blazer’s Cup, a large cannabis festival set to take place beginning on December 2, 2017, in San Bernardino, California.
Khiron Life Sciences Corp. reports the appointment of Mr. Matthew Murphy, the former U.S. Drug Enforcement Administration (“DEA”) Chief of Pharmaceutical Investigations, to the Advisory Board of the Company.
The Green Organic Dutchman Holdings Ltd. is pleased to announce the addition of Marc Bertrand to the Board of Directors and Jeffrey Scott to the Advisory Board.
Aurora Cannabis Inc. (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Namaste Technologies Inc. (CSE: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) today announced that the companies have signed an exclusive hardware supply agreement for the Canadian market.
ChineseInvestors.com, Inc. (OTCQB: CIIX) announced in an 8K SEC filing that Paul Dickman has returned as its chief financial officer, effective September 25, 2017.
There's been a lot of focus lately on InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) breakthrough proprietary biosynthesis technology, and how it could unlock a $6 Billion Industry.
As the marijuana market continues its widespread growth, researchers remain merely at the threshold of exploring the manifold potential medical applications of cannabis.
Vancouver, Canada-based InMed Pharmaceuticals is a preclinical biotech company that specializes in developing novel drug therapies by manufacturing cannabinoids with the potential to have a therapeutic effect on specific diseases.
The cannabidiol market is large and diverse; just a few years ago, it was rather small but by 2015, consumer sales had reached $202 million, according to the CBD Report published by The Hemp Business Journal. Cannabidiol sales are expected to grow to over $2 billion by 2020.
Marapharm Ventures Inc. (CSE: MDM.CN) (FSE: 2M0) (OTCQB: MRPHF) announced today that it has closed escrow and has title and possession of a second cannabis property located in Desert Hot Springs, California for a purchase price of $520,000 USD.
Canopy Health Innovations the partly-owned biopharmaceutical research and development subsidiary of Canopy Growth Corporation (TSX: WEED) today announced that it has filed nine provisional patents pertaining to the applications of cannabis and cannabinoid based therapeutics in sleep and related nervous system disorders
MoneyTrac Technology, Inc. (“MTRAC”), has finalized a majority ownership acquisition of PotSaver, a revenue-producing community periodical providing listings on discounted cannabis-related products for Southern California dispensaries and shops.
